Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibroblast Activating Protein (FAP) PET/CT in Adults With Fibrotic Conditions

NCT06413355 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT06413355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06413355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibroblast Activating Protein (FAP) PET/CT in Adults With Fibrotic Conditions
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
July 16, 2024
Completion date
July 30, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis (morphologic abnormality)